BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ángel GM, Paola VV, Froylan David MS, Lucía PB, Juan Mauricio VZ, María Fernanda NF, Guadalupe MM, Jorge Ignacio FC, Julia María ZV, Olynka VV, Ricardo CR, Rodolfo RP, Luis E MB, Josefina AG, Berenice RJ, Lizette PR, Malaquías LC, de Los Ángeles MM, Victoria BY, Ángeles EC, Guadalupe LC, Angelina LE, Elizabeth GL, Francisco J GP, Daniel CR. Fibroblast growth factor 21 is associated with increased serum total antioxidant capacity and oxidized lipoproteins in humans with different stages of chronic kidney disease. Ther Adv Endocrinol Metab 2021;12:20420188211001160. [PMID: 33854753 DOI: 10.1177/20420188211001160] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
Number Citing Articles
1 Deng J, Liu Y, Liu Y, Li W, Nie X. The Multiple Roles of Fibroblast Growth Factor in Diabetic Nephropathy. J Inflamm Res 2021;14:5273-90. [PMID: 34703268 DOI: 10.2147/JIR.S334996] [Reference Citation Analysis]
2 Zhou X, Zhang Y, Wang N. Regulation and Potential Biological Role of Fibroblast Growth Factor 21 in Chronic Kidney Disease. Front Physiol 2021;12:764503. [PMID: 34675822 DOI: 10.3389/fphys.2021.764503] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]